This open access volume focuses on the development of a P5 eHealth, or better, a methodological resource for developing the health technologies of the future, based on patients’ personal characteristics and needs as the fundamental guidelines for design. It provides practical guidelines and evidence based examples on how to design, implement, use and elevate new technologies for healthcare to support the management of incurable, chronic conditions. The volume further discusses the criticalities of eHealth, why it is difficult to employ eHealth from an organizational point of view or why patients do not always accept the technology, and how eHealth interventions can be improved in the future. By dealing with the state-of-the-art in eHealth technologies, this volume is of great interest to researchers in the field of physical and mental healthcare, psychologists, stakeholders and policymakers as well as technology developers working in the healthcare sector.
This open access volume focuses on the development of a P5 eHealth, or better, a methodological resource for developing the health technologies of the future, based on patients' personal characteristics and needs as the fundamental guidelines for design. It provides practical guidelines and evidence based examples on how to design, implement, use and elevate new technologies for healthcare to support the management of incurable, chronic conditions. The volume further discusses the criticalities of eHealth, why it is difficult to employ eHealth from an organizational point of view or why patients do not always accept the technology, and how eHealth interventions can be improved in the future. By dealing with the state-of-the-art in eHealth technologies, this volume is of great interest to researchers in the field of physical and mental healthcare, psychologists, stakeholders and policymakers as well as technology developers working in the healthcare sector. This work was published by Saint Philip Street Press pursuant to a Creative Commons license permitting commercial use. All rights not granted by the work's license are retained by the author or authors.
This open access volume focuses on the development of a P5 eHealth, or better, a methodological resource for developing the health technologies of the future, based on patients’ personal characteristics and needs as the fundamental guidelines for design. It provides practical guidelines and evidence based examples on how to design, implement, use and elevate new technologies for healthcare to support the management of incurable, chronic conditions. The volume further discusses the criticalities of eHealth, why it is difficult to employ eHealth from an organizational point of view or why patients do not always accept the technology, and how eHealth interventions can be improved in the future. By dealing with the state-of-the-art in eHealth technologies, this volume is of great interest to researchers in the field of physical and mental healthcare, psychologists, stakeholders and policymakers as well as technology developers working in the healthcare sector.
Health and social care systems around the world are facing radical organizational, methodological and technological paradigm changes to meet the requirements for improving quality and safety of care as well as efficiency and efficacy of care processes. In this they’re trying to manage the challenges of ongoing demographic changes towards aging, multi-diseased societies, development of human resources, a health and social services consumerism, medical and biomedical progress, and exploding costs for health-related R&D as well as health services delivery. Furthermore, they intend to achieve sustainability of global health systems by transforming them towards intelligent, adaptive and proactive systems focusing on health and wellness with optimized quality and safety outcomes.
This book describes the multidisciplinary approach needed to tackle better aging. Aging populations are one of the 21st century’s biggest challenges. National health systems are forced to adapt in order to provide adequate and affordable care. Innovation, driven by digital technology, is a key to improving quality of life and encouraging healthy living. Well-designed technology keeps people empowered, independent, and mobile; however, despite widespread adoption of ICT in day-to-day life, digital health technologies have yet to catch on. To this end, technology needs to be effective, usable, cheap, and designed to ensure the security of the managed data. In the era of mHealth, mobile technology, and social design, this book describes, in six sections, the collaboration of polytechnic know-how and social science and health sectors in the creation of a system for encouraging people to engage in healthy behavior and achieve a better quality of life.
The book explores care as a transition strategy to a healthier and more sustainable world. After the lesson learned from the pandemic, health as a fundamental human right is increasingly related to a care component: caring for sick people, persons with disabilities, elders, migrants and refugees, women and children, caring for bodies, minds, cities and nature. Endorsing the care system as a female knowledge based on complexity, flexibility, management of the unexpected, sense of responsibility, the project culture can extract this paradigm from the domestic perimeter, bring outside and make it accessible to all in work, politics, relationships, places and communities. The systemic connection between planet and people wellbeing will be grasped through a transdisciplinary perspective that allows to deal with the city of care at a mental, physical, social and global level. The first section addresses care and interior space, dealing with dwelling, working, proximity and cities on a human scale, with a particular attention to the post Covid conditions. The second section deals with healthcare design, the evolution and trend of healing spaces, the influence of technology and robotics on inclusive design processes. The third section considers a social care attitude and deals with the multiethnic urban dimension, care and creativity in design, society and relationships, the right to health of immigrant people.
This book analyses the ability of technological advancements to represent, enhance, and empower multidisciplinarity in the context of Society 5.0. and next generation medicine. New technologies allow patients to communicate with medical personnel anytime, anywhere and shape the terrain of healthcare ecosystem at an unprecedented rate. Five main trends become apparent in this process: Hybrid care models combining virtual and in-person services, digitization of healthcare specialties, increased Artificial intelligence (AI) adoption, health systems moving to the cloud and advanced precision medicine. In its chapters the book dissects the important roles for technologies in areas such as digital twinning, big data, Internet of Things, AI, cyber-physical systems, blockchain technology to lead the healthcare digitalization envisioned in Society 5.0. Throughout the book the authors discuss how to incorporate these new technologies legally, ethically, safely, and securely and in keeping with the highest standards of human rights. It also advocates for the need for careful oversight and mindful allocation of resources and energy for sustainable development. This book, written by experts in the field from academia and industry, will appeal to researchers, healthcare professionals, policy makers, teachers and students interested in the ways healthcare is reorganized based on digital transformation efforts and the rethinking of care, including technologies.
Artificial Intelligence (AI) has transformed many aspects of our daily activities. Health and well-being of humans stand as one of the key domains where AI has achieved significant progresses, saving time, costs, and potentially lives, as well as fostering economic resilience, particularly under the COVID-19 pandemic environments. This book is a sequel of the Handbook of Artificial Intelligence in Healthcare. The first volume of the Handbook is dedicated to present advances and applications of AI methodologies in several specific areas, i.e., signal, image, and video processing as well as information and data analytics. In this second volume of the Handbook, general practicality challenges and future prospects of AI methodologies pertaining to healthcare and related domains are presented in Part 1 and Part 2, respectively. It is envisaged that the selected studies will provide readers a general perspective on the issues, challenges, and opportunities in designing, developing, and implementing AI-based tools and solutions in the healthcare sector, bringing benefits to transform and advance health and well-being development of humans..
The book is a comprehensive guide that explores the use of artificial intelligence and machine learning in drug discovery and development covering a range of topics, including the use of molecular modeling, docking, identifying targets, selecting compounds, and optimizing drugs. The intersection of Artificial Intelligence (AI) and Machine Learning (ML) within the field of drug design and development represents a pivotal moment in the history of healthcare and pharmaceuticals. The remarkable synergy between cutting-edge technology and the life sciences has ushered in a new era of possibilities, offering unprecedented opportunities, formidable challenges, and a tantalizing glimpse into the future of medicine. AI can be applied to all the key areas of the pharmaceutical industry, such as drug discovery and development, drug repurposing, and improving productivity within a short period. Contemporary methods have shown promising results in facilitating the discovery of drugs to target different diseases. Moreover, AI helps in predicting the efficacy and safety of molecules and gives researchers a much broader chemical pallet for the selection of the best molecules for drug testing and delivery. In this context, drug repurposing is another important topic where AI can have a substantial impact. With the vast amount of clinical and pharmaceutical data available to date, AI algorithms find suitable drugs that can be repurposed for alternative use in medicine. This book is a comprehensive exploration of this dynamic and rapidly evolving field. In an era where precision and efficiency are paramount in drug discovery, AI and ML have emerged as transformative tools, reshaping the way we identify, design, and develop pharmaceuticals. This book is a testament to the profound impact these technologies have had and will continue to have on the pharmaceutical industry, healthcare, and ultimately, patient well-being. The editors of this volume have assembled a distinguished group of experts, researchers, and thought leaders from both the AI, ML, and pharmaceutical domains. Their collective knowledge and insights illuminate the multifaceted landscape of AI and ML in drug design and development, offering a roadmap for navigating its complexities and harnessing its potential. In each section, readers will find a rich tapestry of knowledge, case studies, and expert opinions, providing a 360-degree view of AI and ML’s role in drug design and development. Whether you are a researcher, scientist, industry professional, policymaker, or simply curious about the future of medicine, this book offers 19 state-of-the-art chapters providing valuable insights and a compass to navigate the exciting journey ahead. Audience The book is a valuable resource for a wide range of professionals in the pharmaceutical and allied industries including researchers, scientists, engineers, and laboratory workers in the field of drug discovery and development, who want to learn about the latest techniques in machine learning and AI, as well as information technology professionals who are interested in the application of machine learning and artificial intelligence in drug development.
This seven-volume set LNCS 14054-14060 constitutes the proceedings of the 25th International Conference, HCI International 2023, in Copenhagen, Denmark, in July 2023. For the HCCII 2023 proceedings, a total of 1578 papers and 396 posters was carefully reviewed and selected from 7472 submissions. Additionally, 267 papers and 133 posters are included in the volumes of the proceedings published after the conference, as “Late Breaking Work”. These papers were organized in the following topical sections: HCI Design and User Experience; Cognitive Engineering and Augmented Cognition; Cultural Issues in Design; Technologies for the Aging Population; Accessibility and Design for All; Designing for Health and Wellbeing; Information Design, Visualization, Decision-making and Collaboration; Social Media, Creative Industries and Cultural Digital Experiences; Digital Human Modeling, Ergonomics and Safety; HCI in Automated Vehicles and Intelligent Transportation; Sustainable Green Smart Cities and Smart Industry; eXtended Reality Interactions; Gaming and Gamification Experiences; Interacting with Artificial Intelligence; Security, Privacy, Trust and Ethics; Learning Technologies and Learning Experiences; eCommerce, Digital Marketing and eFinance.
